Document ID: chunk:federal_register_of_legislation:F2021L00609:reg:8
Version: federal_register_of_legislation:F2021L00609
Segment Type: reg
Provision Reference: reg 8
Character Range: 4232–6001

8               Factors that must exist
At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting transverse myelitis or death from transverse myelitis with the circumstances of a person's relevant service:
(1)          having a symptomatic gastrointestinal infection or respiratory tract infection within the 2 months before the clinical onset of transverse myelitis;
(2)          having an infection with a viral, bacterial, fungal or parasitic organism within the 2 months before the clinical onset of transverse myelitis;
(3)          having a systemic autoimmune disease at the time of the clinical onset of transverse myelitis;
(4)          having sarcoidosis at the time of the clinical onset of transverse myelitis;
(5)          having a malignant neoplasm, other than non-melanotic malignant neoplasm of the skin, at the time of the clinical onset of transverse myelitis;
            Note: Transverse myelitis may be part of a paraneoplastic syndrome and the malignant neoplasm may be present but not yet diagnosed at the time of the clinical onset of transverse myelitis.
(6)          taking a drug from the specified list of drugs within the 2 months before the clinical onset of transverse myelitis;
Note: specified list of drugs is defined in the Schedule 1 - Dictionary.
(7)          taking heroin within the 7 days before the clinical onset of transverse myelitis;
(8)          receiving oral polio vaccine within the 2 months before the clinical onset of transverse myelitis;
(9)          having a bone marrow or stem cell transplant before the clinical onset of transverse myelitis;
(10)      inability to obtain appropriate clinical management for transverse myelitis.